Montreux’s Partners have been involved as founders, leaders, managers, investors, and board members in more than 45 healthcare companies over the past 25 years. Our experience comes from deep involvement in building numerous successful companies in our history. A sample of these companies includes Oclassen Pharmaceuticals (acquired by Watson Pharmaceuticals in 1997), Target Therapeutics (acquired by Boston Scientific in 1997), Prograft Medical (acquired by W.L. Gore in 1997), Innovasive Devices (acquired by Johnson & Johnson in 1998), Collagen (acquired by Inamed in 1999), ProDuct Health (acquired by Cytyc in 2001), Interventional Technologies (acquired by Boston Scientific in 2001), Enteric Medical (acquired by Boston Scientific in 2002), Conceptus (NASDAQ: CPTS), Integrated Biosystems (acquired by STEDIM in 2004), Coalescent Surgical (acquired by Medtronic in 2004), Questcor Pharmaceuticals (NASDAQ: QCOR), Peninsula Pharmaceuticals (acquired by Johnson & Johnson in 2005), Somaxon Pharmaceuticals (NASDAQ: SOMX), Cerexa (acquired by Forest Laboratories, 2007), NeurogesX (NASDAQ: NGSX), Orexigen Therapeutics (NASDAQ: OREX), NovaCardia (acquired by Merck, 2007), MAKO Surgical (NASDAQ: MAKO), and Asthmatx (acquired by Boston Scientific, 2010).